Pharmacokinetics under the COVID‐19 storm

AIMS: The storm‐like nature of the health crises caused by COVID‐19 has led to unconventional clinical trial practices such as the relaxation of exclusion criteria. The question remains: how can we conduct diverse trials without exposing subgroups of populations to potentially harmful drug exposure...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Pilla Reddy, Venkatesh, El‐Khateeb, Eman, Jo, Heeseung, Giovino, Natalie, Lythgoe, Emily, Sharma, Shringi, Tang, Weifeng, Jamei, Masoud, Rastomi‐Hodjegan, Amin
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Best Practice for Developing Therapeutics in A Viral Pandemic ‐ Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753415/
https://ncbi.nlm.nih.gov/pubmed/33226664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14668
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars